Evli Likvidi vs UBS Lux Equity Fund Biotech USD

Security

Evli Likvidi B
Fee

0.31%
ISIN

FI0008804463
Holdings

11

Security

UBS Lux Equity Fund Biotech USD P-acc
Fee

2.25%
ISIN

LU0069152568
Holdings

5

Fund Holdings

We have information about 11 holdings in Evli Likvidi, where the largest holding is Teollisuuden Voima (1.86), followed by Nordea (1.74) and Akelius (1.4). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in Evli Likvidi and UBS Lux Equity Fund Biotech USD.

Evli Likvidi	UBS Lux Equity Fund Biotech USD
1. Teollisuuden Voima Oyj 1.86 %	1. Regeneron Pharmaceuticals Inc 10.04 %
2. Nordea Bank Abp 1.74 %	2. Moderna Inc 9.21 %
3. Akelius Residential D 1.4 %	3. Gilead Sciences Inc 4.66 %
4. Kojamo Oyj 1.19 %	4. BioNTech SE 4.13 %
5. SSAB B 1.18 %	5. Karuna Therapeutics Inc 3.75 %
6. Luminor Bank AS 1.15 %	-
7. Stora Enso Oyj R 1.14 %	-
8. Fortum Oyj 1.08 %	-
9. Akelius Residential Property Finance BV 1.05 %	-
10. Skanska B 1.04 %	-
11. Vestas Wind Systems A/S 1.03 %	-

The list of fund holdings was last updated on September 10, 2025.